ArticleJournal of the Canadian Association of Gastroenterology2026

Effectiveness of vedolizumab dose escalation in inflammatory bowel disease in a large-scale, Canadian real-world cohort.

Edmond-Jean Bernard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.